Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ralf Baron, Victor Mayoral, Göran Leijon, Andreas Binder, Ilona Steigerwald & Michael Serpell. (2009) Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Current Medical Research and Opinion 25:7, pages 1677-1687.
Read now
Read now
Ralf Baron, Victor Mayoral, Göran Leijon, Andreas Binder, Ilona Steigerwald & Michael Serpell. (2009) 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Current Medical Research and Opinion 25:7, pages 1663-1676.
Read now
Read now
Articles from other publishers (21)
Yanhao Chu, Hongwen He, Qing Liu, Shilin Jia, Wenguo Fan & Fang Huang. (2022) The Circadian Clocks, Oscillations of Pain-Related Mediators, and Pain. Cellular and Molecular Neurobiology 43:2, pages 511-523.
Crossref
Crossref
Christine Bader, Diane Flynn, Chester Buckenmaier, Catherine McDonald, Salimah Meghani, Christian Calilung & Rosemary Polomano. (2021) Comparative Analysis of Health Domains for Neuropathic Pain Patients. Clinical Nursing Research 31:1, pages 89-99.
Crossref
Crossref
Benoit Sion & Mélina Bégou. (2021) Can chronopharmacology improve the therapeutic management of neurological diseases?. Fundamental & Clinical Pharmacology 35:3, pages 564-581.
Crossref
Crossref
Julia P. Segal, Kaitlyn A. Tresidder, Charvi Bhatt, Ian Gilron & Nader Ghasemlou. (2018) Circadian control of pain and neuroinflammation. Journal of Neuroscience Research 96:6, pages 1002-1020.
Crossref
Crossref
Neel Mehta, Iwona Bucior, Shay Bujanover, Rajiv Shah & Amitabh Gulati. (2016) Relationship between pain relief, reduction in pain-associated sleep interference, and overall impression of improvement in patients with postherpetic neuralgia treated with extended-release gabapentin. Health and Quality of Life Outcomes 14:1.
Crossref
Crossref
Ian Gilron. (2016) Impact of chronobiology on neuropathic pain treatment. Pain Management 6:3, pages 241-247.
Crossref
Crossref
Anne M. Calkins, Jeff Gudin, Barry Gidal, Mark J. Jaros, Richard Kim & Gwendoline Shang. (2016) Impact of Data Imputation Methodology on Pain Assessment over 24 Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated with Postherpetic Neuralgia. Pain Medicine, pages pnv072.
Crossref
Crossref
Jemily Malvar, Florin Vaida, Chelsea Fitzsimons Sanders, J. Hampton Atkinson, William Bohannon, John Keltner, Jessica Robinson-Papp, David M. Simpson, Christina M. Marra, David B. Clifford, Benjamin Gelman, Juanjuan Fan, Igor Grant & Ronald J. Ellis. (2015) Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. Pain 156:4, pages 731-739.
Crossref
Crossref
Ian Gilron, Joan M. Bailey & Elizabeth G. Vandenkerkhof. (2013) Chronobiological Characteristics of Neuropathic Pain. The Clinical Journal of Pain 29:9, pages 755-759.
Crossref
Crossref
Gordon Irving. (2012) Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians. Therapeutic Advances in Chronic Disease 3:5, pages 211-218.
Crossref
Crossref
David Sandercock, Marilou Cramer, Victor Biton & Verne E. Cowles. (2012) A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: Efficacy and tolerability in a double-blind, randomized, controlled clinical trial. Diabetes Research and Clinical Practice 97:3, pages 438-445.
Crossref
Crossref
Lynn Stazzone & Brandon Brown. 2012. Multiple Sclerosis. Multiple Sclerosis
213
238
.
Cristiana Guetti, Chiara Angeletti, Franco Marinangeli, Alessandra Ciccozzi, Giada Baldascino, Antonella Paladini & Giustino Varrassi. (2010) Transdermal Buprenorphine for Central Neuropathic Pain: Clinical Reports. Pain Practice 11:5, pages 446-452.
Crossref
Crossref
Jacques Devulder. (2010) Flupirtine in Pain Management. CNS Drugs 24:10, pages 867-881.
Crossref
Crossref
Ralf Baron, Victor Mayoral, Göran Leijon, Andreas Binder, Ilona Steigerwald & Michael Serpell. (2009) Efficacy and Safety of 5% Lidocaine (Lignocaine) Medicated Plaster in Comparison with Pregabalin in Patients with Postherpetic Neuralgia and Diabetic Polyneuropathy. Clinical Drug Investigation 29:4, pages 231-241.
Crossref
Crossref
Thrasivoulos G. Tzellos, Georgios Papazisis, Ekaterini Amaniti & Dimitrios Kouvelas. (2008) Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature. European Journal of Clinical Pharmacology 64:9, pages 851-858.
Crossref
Crossref
George R. Hansen. (2005) Management of Chronic Pain in the Acute Care Setting. Emergency Medicine Clinics of North America 23:2, pages 307-338.
Crossref
Crossref
Funda Levendoğlu, Cemile Ö. Öğün, Önder Özerbil, Tunç C. Öğün & Hatice Uğurlu. (2004) Gabapentin Is a First Line Drug for the Treatment of Neuropathic Pain in Spinal Cord Injury. Spine 29:7, pages 743-751.
Crossref
Crossref
Joan Domigan Wents. (2003) Comprender el dolor neurop?tico. Nursing (Ed. espa?ola) 21:7, pages 52.
Crossref
Crossref
JOSEPH J. KEENEJR.JR., GAIL T. GALASKO & MARTIN F. LAND. (2003) Antidepressant use in psychiatry and medicine. The Journal of the American Dental Association 134:1, pages 71-79.
Crossref
Crossref
JOAN DOMIGAN WENTZ. (2003) Understanding neuropathic pain. Nursing 33:1, pages 22.
Crossref
Crossref